XBIT Stock Analysis: Buy, Sell, or Hold?
XBIT - XBiotech Inc
$2.51
-0.03 (-1.18%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 17, 2026
Get Alerted When XBIT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: XBIT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: XBIT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: XBIT is currently trading at $2.51, which is considered fair relative to its 30-day fair value range of $2.43 to $2.63.
Technical Outlook: Technically, XBIT is in a downtrend. The price is currently testing key support at $2.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (10th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $18.00 (+608.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, XBIT is in a downtrend. The price is currently testing key support at $2.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (10th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $18.00 (+608.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$2.43 -
$2.63
Company Quality Score
53/100
(HOLD)
Options IV Signal
10th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
80.0%
Protect Your Profits
Holding XBIT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 10th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 608.7% below Wall St target ($18.00)
- CAUTION: Recommendation downgraded due to -6.3% 5-day decline
Fair Price Analysis
30-Day Fair Range
$2.43 -
$2.63
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$0.56
(22.3%)
Support & Resistance Levels
Support Level
$2.46
Resistance Level
$2.73
Current Trend
Downtrend
Fundamental Context
Wall Street Target
$18.00
(+608.7%)
Revenue Growth (YoY)
-93.3%
Last updated: January 30, 2026 5:41 PM ET
Data refreshes hourly during market hours. Next update: 6:41 PM
Data refreshes hourly during market hours. Next update: 6:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XBIT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
Advanced XBIT Option Strategies
Professional options setups generated by AI based on today's XBIT price and gamma walls.
